Last reviewed · How we verify
NCT06602388: HIBISCUS
Human Internal BIOASTER's Samples Collection
trial testing Biological sampling in Biological Samples in 120 participants. Not yet recruiting.
31 December 2027
Quick facts
| Lead sponsor | Bioaster |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 30 December 2024 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2027 |
Drugs / interventions tested
- Biological sampling — full drug profile →
Conditions studied
- Biological Samples — all drugs for Biological Samples →
Sponsor
Bioaster — full company profile →
Who can join
18 and older, any sex, with Biological Samples. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
BIOASTER is a Technological Research Institute dedicated to microbiology and infectious diseases. BIAOSTER s areas of expertise are organized around four research programs: 1/ Antimicrobials; 2/ Vaccines; 3/ Microbiota; 4/ Diagnostics. Hibiscus is a non-interventional, monocentric study aimed at building up a a collection of biological samples (stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair) collected from BIOASTER employees. These samples to be used for scientific purposes including the technological development of Bioaster s collaborative and in-house research projects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06602388
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biological sampling
Trials testing the same drug.
- NCT05970965 — Periodontitis and Inflammation in Children With Down Syndrome/Trisomy 21: Study on Biological Samples · NA · recruiting
- NCT06890078 — Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients · not yet recruiting
- NCT06828458 — Determining Elements of Anti-Fungal Immunity in BURN Patients · not yet recruiting
- NCT06690151 — Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal · recruiting
- NCT07017348 — Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic Dermatitis · NA · completed
Other Bioaster trials
Trials by the same sponsor.
- NCT05972590 — Characterization of Fecal Microbiota in a Population Aged 50 to 75 Years Targeted by Seasonal Vaccination · NA · completed
- NCT05701371 — BACTERIA ISOLATION FROM STOOLS COLLECTED FROM CENTENARIANS PEOPLE · terminated
- NCT06862531 — A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06602388 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bioaster
- Last refreshed: 20 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06602388.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing